Guizhou Miracle Pharmaceutical Co., Ltd., a well-known pharmaceutical brand, began in 1990, Guizhou Province famous brand products, specializing in anti-tumor, cardiovascular and cerebrovascular, cold and cough, children's medicine and antifungal drugs research and development, production and sales of high-tech enterprises
Miracle Pharmaceutical is a company specializing in the research and development, production and sales of anti-tumor, cardiovascular and cerebrovascular, cold and cough, children's drugs and antifungal drugs, the company has a "magical" brand, with more than 20 years of business history, Miracle Pharmaceutical was rated as "Guizhou Excellent Private Enterprise". The "magical" brand has a high reputation and reputation among dealers and consumers. In recent years, the sub-brands "Quick Stop" and "Magic Doll" have also gained good brand recognition.
The company has 5 production bases of "Guiyang" and "Longli", covering an area of about 600 acres, and currently has 42 dosage form production lines such as "tablets, capsules, sprays, films, granules, syrup, tinctures, injections", etc., all of which have passed the national and provincial GMP (Good Manufacturing Practice) certification. At present, the new plant area is being invested and constructed in Guiyang National High-tech Industrial Development Zone, covering an area of 300 acres, and is planned to be completed and put into operation in 3 to 5 years.
The company's capabilities in R&D and technological innovation are widely recognized. It has Guizhou Miao Medicine Engineering Technology Center. At the same time, it has also established long-term cooperative relations with well-known pharmaceutical research institutions at home and abroad. At present, 8 national medicines with independent intellectual property rights have been developed, and 75 national invention patents have been developed. Guizhou Miracle Pharmaceutical Co., Ltd. is a national manufacturing informatization demonstration enterprise and an advanced unit of intellectual property pilot demonstration in Guizhou Province.
The company has 145 drug approval numbers, and has good product quality, product planning and product structure matching, which can ensure the sustainable growth of its profitability. Among them, the cough suppressant series products are the leading brands of respiratory drugs in China, and the sodium cantharidate API and injection are the exclusive products in China, which are new anti-tumor drugs with the effect of stimulating bone marrow hematopoietic function and increasing white blood cells.
The company's products have both OTC and prescription drugs, the main varieties on sale are loquat cough granules, strong loquat dew, loquat cough capsules, pediatric aminophenamine granules, pediatric pharyngeal flat granules, pediatric detoxification syrup, silver cup heart pulse drop pills, silver dan xintai drop pills, coral ringworm net, sodium cantharid acid injection, sodium cantharid acid vitamin B6 injection, ginseng polysaccharide injection, Jin Wu Gutong capsule, Jingwu capsule, Tianma capsule, etc., 35 products have entered the medical insurance catalog or essential drug list, the company in 31 provinces (cities) in the country More than 100 cities above the prefecture level have sales networks.
While the company develops and grows, it has always maintained a strong sense of social responsibility and has not forgotten to repay the society. It has donated more than 200 million yuan to pave roads and bridges in Guizhou, based on the actual situation of Guizhou to help farmers in poor areas develop production, build primary and secondary schools and youth activity centers, and funded the establishment of "Poor Student Grants" in Beijing University of Traditional Chinese Medicine, Shenyang Pharmaceutical University and Guizhou University for Nationalities to help poor students complete their studies. In March 2002, through the Ministry of Health, the Ministry of Health provided 120 million yuan of anti-tuberculosis drugs to 12 impoverished counties in Africa and West China free of charge, and implemented the "Glorious Rehabilitation Project".
The company takes pharmaceutical investment as the strategic development direction and adheres to the strategic policy of "being practical, stronger, bigger and thorough"; With the help of the power of the capital market, through investment, cooperation, mergers, acquisitions, reorganization, etc., we will integrate organizations, models, resources, brands and cultures, expand and strengthen the pharmaceutical industry, and strive to develop into a leading health industry cluster in the domestic pharmaceutical industry with modern Chinese patent medicine as the core.
